Xero has fallen on a $3.9 bn Melio deal funded by a capital raise, while Neuren advanced on a US patent for its Pitt Hopkins therapy.
Osteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won’t distract it from its key phase III knee trial.
Property investors are already making widespread losses with inner-city apartments, now further tax pain is on the agenda.
X2M Connect discusses a $3 million safety deal with Seoul and its broader vision of a global rollout into smart city infrastructure.
Norwest Minerals will launch a drilling campaign in mid-July to grow gold resources at its Bulgera project.
